FDA Adverse Event Injury Summary report: N

ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP

MDR report key: 1933888 · Received December 21, 2010

Report

Report Number
3005099803-2010-05173
Event Type
Injury
Date Received
December 21, 2010
Date of Event
November 24, 2010
Report Date
November 26, 2010
Manufacturer
BOSTON SCIENTIFIC - SPENCER
Product Code
KNT
PMA / PMN Number
K081739
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SE
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4) - EXCHANGE OF J-TUBE. (B)(4) - THE REPORTED EVENT OF J-TUBE KINKED. THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A TWO PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE) WAS BEING USED FOR THE PURPOSE OF ADMINISTERING MEDICATION FOR ADVANCED STAGE PARKINSON'S DISEASE. THE J-TUBE WAS PLACED ON (B)(6), 2010. ACCORDING TO THE COMPLAINANT, ON (B)(6), 2010 THE PATIENT PRESENTED WITH A KINKED J-TUBE. A ESOPHAGOGASTRODUODENOSCOPY WAS USED TO EXCHANGE THE J-TUBE. A NEW 80CMTWO PORT THROUGH THE PEG JEJUNAL FEEDING TUBE (J-TUBE) WAS PLACED. IT WAS REPORTED THAT THE PATIENT DID NOT EXPERIENCE ANY HEALTH RELATED IMPAIRMENT. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOVIVE TWO-PORT TTP JEJUNAL FEEDING TUBE CAP TUBES, GASTROINTESTINAL (AND ACCESSORIES) KNT BOSTON SCIENTIFIC - SPENCER UNK443

Patients

Seq Age Sex Outcome Treatment
1 59 YR Other DUODOPA